Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to 0.14%.

  • Strata Critical Medical's Return on Invested Capital rose 1400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.15% for FY2024, which is 1100.0% up from last year.
  • As of Q3 2025, Strata Critical Medical's Return on Invested Capital stood at 0.14%, which was up 1400.0% from 0.17% recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Return on Invested Capital registered a high of 0.06% during Q3 2021, and its lowest value of 0.27% during Q3 2024.
  • Its 5-year average for Return on Invested Capital is 0.18%, with a median of 0.19% in 2022.
  • Per our database at Business Quant, Strata Critical Medical's Return on Invested Capital soared by 1700bps in 2021 and then plummeted by -1000bps in 2022.
  • Strata Critical Medical's Return on Invested Capital (Quarter) stood at 0.09% in 2021, then tumbled by -106bps to 0.19% in 2022, then tumbled by -43bps to 0.27% in 2023, then increased by 24bps to 0.2% in 2024, then soared by 31bps to 0.14% in 2025.
  • Its Return on Invested Capital was 0.14% in Q3 2025, compared to 0.17% in Q2 2025 and 0.2% in Q1 2025.